Live Breaking News & Updates on William Scalzo

Stay updated with breaking news from William scalzo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dyne Therapeutics (NASDAQ:DYN) Price Target Raised to $31.00

Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price objective increased by Chardan Capital from $20.00 to $31.00 in a research report sent to investors on Friday morning, Stock Target Advisor reports. Chardan Capital currently has a buy rating on the stock. Several other equities research analysts have also recently issued reports on the stock. […] ....

United States , Stifel Nicolaus , Zurcher Kantonalbank Zurich Cantonalbank , Piper Sandler , Dirk Kersten , Richard William Scalzo , Dyne Therapeutics Inc , Sphera Funds Management , Allspring Global Investments Holdings , Securities Exchange Commission , Royal Bank , Ameritas Investment Partners Inc , Dyne Therapeutics , Free Report , Chardan Capital , Stock Target Advisor , Moderate Buy , Get Free Report , Director Dirk Kersten , Exchange Commission , William Scalzo , Investment Partners , Kantonalbank Zurich Cantonalbank , Global Investments Holdings , Dyne Therapeutics Daily , Nasdaq Dyn ,

Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) SVP Sells 13,000 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) SVP Richard William Scalzo sold 13,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $24.34, for a total value of $316,420.00. Following the transaction, the senior vice president now directly owns 124,228 […] ....

United States , Raymond James , Richard William Scalzo , Blackrock Inc , Dyne Therapeutics Inc , Securities Exchange Commission , Vr Adviser , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , William Scalzo , Exchange Commission , Street Corp , Goldman Sachs Group , Sachs Group , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Dyne Therapeutics, Inc. (NASDAQ:DYN) SVP Richard William Scalzo Sells 13,000 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) SVP Richard William Scalzo sold 13,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $24.34, for a total transaction of $316,420.00. Following the completion of the sale, the senior vice president now […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Richard William Scalzo , Royal Bank , Sphera Funds Management , China Universal Asset Management Co , Dyne Therapeutics Inc , Dyne Therapeutics Company Profile , Ameritas Investment Partners Inc , Dyne Therapeutics , Get Free Report , William Scalzo , Investment Partners , Universal Asset Management , Funds Management , Kantonalbank Zurich Cantonalbank , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,